Tetracycline Three Times Daily Versus Four Times Daily in Bismuth-Containing Quadruple Therapy as the First-Line Treatment of Helicobacter pylori Infection: A Multicenter, Noninferiority, Randomized Controlled Trial.

Yu-Ming DingQiu-Mei ZhangRui-Li LiZhong-Xue HanQing ZhaoLi-Dong XuKe-Yu WangXue-Ping NanMiao DuanShu-Yan ZengQing-Zhou KongHui WangXiao-Qi WuNing ZhangYan-Qing LiXiu-Li Zuo Yue-Yue Li

Published in: Helicobacter (2024)

ClinicalTrials.gov identifier: NCT05431075.

Keyphrases

helicobacter pylori infection
randomized controlled trial
helicobacter pylori
physical activity
study protocol
visible light
systematic review
stem cells